#87 Daily multivitamins to reduce mortality, cardiovascular disease, and cancer
CLINICAL QUESTION
Does daily multivitamin supplementation reduce mortality, cardiovascular disease (CVD), and/or cancer?
BOTTOM LINE
Present evidence does not support the routine use of multivitamins to reduce mortality, cardiovascular disease, or cancer for people in developed countries.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
A meta-analysis and one Randomized Controlled Trial (RCT).
Meta-analysis1 of 21 RCTs (including RCT below) with 91,074 patients (54% males) randomized to multivitamins or placebo for 3.5 years. Most are primary prevention studies from Europe or North America
- No effect on overall mortality: Relative Risk (RR)=0.98 (0.94-1.02).
- No effect on cancer mortality: RR=0.96 (0.88-1.04).
- No effect on CVD mortality: RR=1.01 (0.93-1.09).
- Multiple subgroup testing found no differences.
- No evidence of publication bias or meaningful heterogeneity.
- No effect on overall mortality: Hazard Ratio (HR)=0.94 (0.88-1.02).
- No effect on cancer mortality: HR=0.88 (0.77-1.01).
- No effect on CVD mortality: HR=0.95 (0.83-1.09).
- No effect on CVD events: HR=1.01 (0.91-1.10).
- Reduced cancer incidence: HR=0.92 (0.86-0.998).
- These were adjusted (for unclear reasons).
- Unadjusted is not significant RR=0.94 (0.87-1.003).
- Multiple issues: Lots of exclusion including run-in to remove non-compliant patients, adjustments (without clear reason) always in favor of multivitamins.
- Multiple cohort studies have found no mortality reduction with multivitamins.
- Vitamin supplementation may help reduce overall mortality in undernourished populations (like rural China). 8
- However, in this RCT8 of four different vitamin interventions, only one reduced mortality RR=0.91 (0.84-0.99).
- Meta-analyses of different vitamin components on mortality:
- B-Vitamins:9 No effect.
- Anti-oxidants:10 Increase mortality RR=1.04 (1.01-1.07).
- Increase with vitamin E, beta-carotene and high-dose vitamin A.
- No effect from vitamin C and selenium.
- Vitamin D:11 Decrease mortality RR=0.97 (0.94-1.00)
- Increases and decreases are small [Numbers Needed to Harm (NNH) or treat around 200 over five years].
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
